Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 38

Cited In for PubMed (Select 18923441)

1.

MiR-148b suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting WNT1/β-catenin pathway.

Zhang JG, Shi Y, Hong DF, Song M, Huang D, Wang CY, Zhao G.

Sci Rep. 2015 Jan 28;5:8087. doi: 10.1038/srep08087.

2.

HPV16 early gene E5 specifically reduces miRNA-196a in cervical cancer cells.

Liu C, Lin J, Li L, Zhang Y, Chen W, Cao Z, Zuo H, Chen C, Kee K.

Sci Rep. 2015 Jan 7;5:7653. doi: 10.1038/srep07653.

3.

Dosage and temporal thresholds in microRNA proteomics.

Lee T, Wang N, Houel S, Couts K, Old W, Ahn N.

Mol Cell Proteomics. 2015 Feb;14(2):289-302. doi: 10.1074/mcp.M114.043851. Epub 2014 Dec 2.

PMID:
25467838
4.

An extended gene protein/products Boolean network model including post-transcriptional regulation.

Benso A, Di Carlo S, Politano G, Savino A, Vasciaveo A.

Theor Biol Med Model. 2014 May 7;11 Suppl 1:S5. doi: 10.1186/1742-4682-11-S1-S5. Epub 2014 May 7.

5.

Prospective evaluation of whole genome microRNA expression profiling in childhood acute lymphoblastic leukemia.

Duyu M, Durmaz B, Gunduz C, Vergin C, Yilmaz Karapinar D, Aksoylar S, Kavakli K, Cetingul N, Irken G, Yaman Y, Ozkinay F, Cogulu O.

Biomed Res Int. 2014;2014:967585. doi: 10.1155/2014/967585. Epub 2014 May 14.

6.

MicroRNA-128-3p is a novel oncomiR targeting PHF6 in T-cell acute lymphoblastic leukemia.

Mets E, Van Peer G, Van der Meulen J, Boice M, Taghon T, Goossens S, Mestdagh P, Benoit Y, De Moerloose B, Van Roy N, Poppe B, Vandesompele J, Wendel HG, Van Vlierberghe P, Speleman F, Rondou P.

Haematologica. 2014 Aug;99(8):1326-33. doi: 10.3324/haematol.2013.099515. Epub 2014 Jun 3.

7.

Polymorphisms in microRNA target sites modulate risk of lymphoblastic and myeloid leukemias and affect microRNA binding.

Dzikiewicz-Krawczyk A, Macieja A, Mały E, Januszkiewicz-Lewandowska D, Mosor M, Fichna M, Strauss E, Nowak J.

J Hematol Oncol. 2014 Jun 2;7:43. doi: 10.1186/1756-8722-7-43.

8.

Epigenetic modifications in pediatric acute lymphoblastic leukemia.

Burke MJ, Bhatla T.

Front Pediatr. 2014 May 14;2:42. doi: 10.3389/fped.2014.00042. eCollection 2014. Review.

9.

Environmental exposures in utero and microRNA.

Kappil M, Chen J.

Curr Opin Pediatr. 2014 Apr;26(2):243-51. doi: 10.1097/MOP.0000000000000073. Review.

10.

MicroRNA-196a promotes cervical cancer proliferation through the regulation of FOXO1 and p27Kip1.

Hou T, Ou J, Zhao X, Huang X, Huang Y, Zhang Y.

Br J Cancer. 2014 Mar 4;110(5):1260-8. doi: 10.1038/bjc.2013.829. Epub 2014 Jan 14.

11.

Molecular and Epigenetic Mechanisms of MLL in Human Leukemogenesis.

Ballabio E, Milne TA.

Cancers (Basel). 2012 Sep 10;4(3):904-44. doi: 10.3390/cancers4030904.

12.

Targeting connective tissue growth factor (CTGF) in acute lymphoblastic leukemia preclinical models: anti-CTGF monoclonal antibody attenuates leukemia growth.

Lu H, Kojima K, Battula VL, Korchin B, Shi Y, Chen Y, Spong S, Thomas DA, Kantarjian H, Lock RB, Andreeff M, Konopleva M.

Ann Hematol. 2014 Mar;93(3):485-92. doi: 10.1007/s00277-013-1939-2. Epub 2013 Oct 24.

13.

A systematic analysis of a mi-RNA inter-pathway regulatory motif.

Di Carlo S, Politano G, Savino A, Benso A.

J Clin Bioinforma. 2013 Oct 24;3(1):20. doi: 10.1186/2043-9113-3-20.

14.

MiR-130b is a prognostic marker and inhibits cell proliferation and invasion in pancreatic cancer through targeting STAT3.

Zhao G, Zhang JG, Shi Y, Qin Q, Liu Y, Wang B, Tian K, Deng SC, Li X, Zhu S, Gong Q, Niu Y, Wang CY.

PLoS One. 2013 Sep 10;8(9):e73803. doi: 10.1371/journal.pone.0073803. eCollection 2013. Erratum in: PLoS One. 2013;8(9). doi:10.1371/annotation/497d9208-190a-44b7-ac27-aea12183f47c.

15.

MicroRNA-196b regulates the homeobox B7-vascular endothelial growth factor axis in cervical cancer.

How C, Hui AB, Alajez NM, Shi W, Boutros PC, Clarke BA, Yan R, Pintilie M, Fyles A, Hedley DW, Hill RP, Milosevic M, Liu FF.

PLoS One. 2013 Jul 4;8(7):e67846. doi: 10.1371/journal.pone.0067846. Print 2013.

16.

Oxidative stress mediated-alterations of the microRNA expression profile in mouse hippocampal neurons.

Xu S, Zhang R, Niu J, Cui D, Xie B, Zhang B, Lu K, Yu W, Wang X, Zhang Q.

Int J Mol Sci. 2012 Dec 11;13(12):16945-60. doi: 10.3390/ijms131216945.

17.

MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies.

Sionov RV.

ISRN Hematol. 2013;2013:348212. doi: 10.1155/2013/348212. Epub 2013 Jan 29.

18.

Integrative analysis of somatic mutations altering microRNA targeting in cancer genomes.

Ziebarth JD, Bhattacharya A, Cui Y.

PLoS One. 2012;7(10):e47137. doi: 10.1371/journal.pone.0047137. Epub 2012 Oct 16.

19.

Modulating the strength and threshold of NOTCH oncogenic signals by mir-181a-1/b-1.

Fragoso R, Mao T, Wang S, Schaffert S, Gong X, Yue S, Luong R, Min H, Yashiro-Ohtani Y, Davis M, Pear W, Chen CZ.

PLoS Genet. 2012;8(8):e1002855. doi: 10.1371/journal.pgen.1002855. Epub 2012 Aug 9.

20.

Gene expression profiling and candidate gene resequencing identifies pathways and mutations important for malignant transformation caused by leukemogenic fusion genes.

Novak RL, Harper DP, Caudell D, Slape C, Beachy SH, Aplan PD.

Exp Hematol. 2012 Dec;40(12):1016-27. doi: 10.1016/j.exphem.2012.08.001. Epub 2012 Aug 8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk